Precision's Galante Addresses 21st Century Cures Act and Future Utilization of Real-World Evidence in Clinical Leader

 

In the latest edition of Clinical Leader, Precision for Value’s Dominic Galante addresses how real-world evidence is being leveraged after the adoption of the 21st Century Cures Act, and provides some next steps for life science companies. 

To read the complete commentary, please click here.